# FDA EIR - Eli Lilly & Company - March 20, 2020

Source: https://www.keypedia.com/records/eir/eli-lilly-company/9e8da9ed-234b-4013-bd23-c71b99acb878

> FDA EIR for Eli Lilly & Company on March 20, 2020. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Eli Lilly & Company
- Inspection Date: 2020-03-20

## Related Documents

- [483 - 2023-06-16](https://www.keypedia.com/records/483/eli-lilly-company/ad3d5c22-c165-4f63-91cc-163c31217be2)
- [483 - 2023-10-06](https://www.keypedia.com/records/483/eli-lilly-company/f0349542-8a47-4147-9164-7ecacf1fcd4e)
- [483 - 2021-03-16](https://www.keypedia.com/records/483/eli-lilly-company/9fdf10fc-bc85-478c-affd-9279176c5cb7)
- [483_RESPONSE - 2021-03-16](https://www.keypedia.com/records/483_response/eli-lilly-company/48bca0f9-fb52-4f51-9e65-4d0fd6283a21)
- [WARNING_LETTER_RESPONSE - 2001-02-23](https://www.keypedia.com/records/warning_letter_response/eli-lilly-company/e90881d9-e2fa-473e-ab9d-4415ee00f701)

## Related Officers

- [U.S. Food and Drug Administration](https://www.keypedia.com/people/myra-k-casey/a2fae714-2ba3-4c60-9f54-990fc7b169c9)
- [Ms.](https://www.keypedia.com/people/joanne-m-givens/7d6d17bd-5f41-4cdf-8f88-488b560f73f8)
- [Ms.](https://www.keypedia.com/people/vickilee-k/7443ab3a-6965-425d-a467-86e07210442c)
- [Mr.](https://www.keypedia.com/people/jonathan-e-sterling/33451d8a-6070-43eb-a2e9-281878cacdbb)
- [Dr.](https://www.keypedia.com/people/mark-f-binkley/7149a155-dfd4-4767-9b56-7f3ece4809cc)

Company: https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf